Effect of hemodialysis on the antioxidative properties of serum

Biochimica et Biophysica Acta - Molecular Basis of Disease

Volumn 1638, Issue 3, 2003, Pages 267-272

  Mayer, Birgit ^a   Zitta, Sabine ^b   Greilberger, Joachim ^b   Holzer, Herwig ^b   Reibnegger, Gilbert ^b   Hermetter, Albin ^a   Oettl, Karl ^b  

^a GRAZ UNIVERSITY OF TECHNOLOGY   (Austria)

^b UNIVERSITY OF GRAZ   (Austria)

Author keywords

Antioxidant; End stage renal disease; Free radical; Hemodialysis; Oxidative stress

Indexed keywords

ANTIOXIDANT; CARBONYL DERIVATIVE; LIPID; PLASMA PROTEIN; PROTEIN; TROLOX C;

ADULT; ARTICLE; ARTIFICIAL KIDNEY; CLINICAL ARTICLE; CONTROLLED STUDY; DATA ANALYSIS; DIALYSIS; FEMALE; HEMODIALYSIS; HUMAN; KIDNEY ARTERY; KIDNEY BLOOD VESSEL; KIDNEY FAILURE; LIPID BLOOD LEVEL; LIPID OXIDATION; MALE; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN MODIFICATION; AGED; BLOOD; BLOOD ANALYSIS; CHEMISTRY; CHRONIC KIDNEY FAILURE; METABOLISM; MIDDLE AGED; MONITORING; OXIDATION REDUCTION REACTION; RENAL REPLACEMENT THERAPY; TIME;

ADULT; AGED; AGED, 80 AND OVER; ANTIOXIDANTS; BLOOD; BLOOD CHEMICAL ANALYSIS; FEMALE; HUMANS; KIDNEY FAILURE, CHRONIC; LIPIDS; MALE; MIDDLE AGED; MONITORING, PHYSIOLOGIC; OXIDATION-REDUCTION; PROTEINS; RENAL DIALYSIS; TIME FACTORS;

EID: 0141543903     PISSN: 09254439     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4439(03)00093-0     Document Type: Article

References (49)

1. Foley R.N., Parfrey P.S., Sarnack M.J. Cardiovascular diseases in chronic renal failure. Am. J. Kidney Dis. 32:1998;S112-S119.
2. Rigatto C., Singal P.K. Oxidative stress in uremia: impact on cardiac disease in dialysis patients. Sem. Dial. 12:1999;91-96.
3. Kuwahara T., Market M., Wauters J.P. Neutrophil oxygen radical production by dialysis membranes. Nephrol. Dial. Transplant. 3:1988;661-665.
4. Nguyen A.T., Lethias C., Zingraff J., Herbelin A., Naret C., Descamps-Latscha B. Hemodialysis membrane-induced activation of phagocyte oxidative metabolism detected in vivo within micro amounts of whole blood. Kidney Int. 28:1985;58-167.
5. Handelman G.J., Walter M.F., Adhikarla R., Gross J., Dallal G.E., Levin N.W., Blumberg J.B. Elevated plamsa F2-isoprostanes in patients on long-term hemodialysis. Kidney Int. 59:2001;1960-1966.
6. Maggi E., Bellazzi R., Gazo A., Seccia M., Bellomo G. Autoantibodies against oxidatively-modified LDL in uremic patients undergoing dialysis. Kidney Int. 46:1994;869-876.
7. Morane M., Cristol J.P., Canaud B. Why hemodialysis patients are in a prooxidant state? What could be done to correct the pro/antioxidant imbalance. Blood Purif. 18:2000;191-199.
8. Weinstein T., Chagnac A., Korzets A., Boaz M., Ori Y., Herman M., Malachi T., Gafter U. Hemodialysis in hemodialysis patients: evidence for impaired defence mechanisms against oxidative stress. Nephrol. Dial. Transplant. 15:2000;883-887.
9. Miyazaki H., Matsuoka H., Itabe H., Usui M., Ueda S., Okuda S., Imaizumi T. Hemodialysis impairs endothelial function via oxidative stress: effects of vitamin E-coated dialyzer. Circulation. 101:2000;1002-1006.
10. Miyata T., Kurokawa K., Van Ypersele de Strihou C. Relevance of oxidative and carbonyl stress to long-term uremic complications. Kidney Int. 58(Suppl. 76):2000;S120-S125.
11. Nourooz-Zadeh J. Effect of dialysis on oxidative stress in uremia. Redox Rep. 4:1999;17-22.
12. Hirayama A., Nagase S., Gotoh M., Takemura K., Tomida C., Ueda A., Aoyagi K., Terao J., Koyama A. Hemodialysis does not influence the peroxidative state already present in uremia. Nephron. 86:2000;436-440.
13. Himmelfarb J., McMenamin M.E., Loseto G., Heinecke J.W. Myeloperoxidase-catalysed 3-chlorotyrosine formation in dialysis patients. Free Radic. Biol. Med. 31:2001;1163-1169.
14. Rice-Evans C., Miller N.J. Total antioxidant status in plasma and body fluids. Methods Enzymol. 234:1994;279-293.
15. Miller N.J., Rice-Evans C., Davies M.J., Gopinathan V., Milner A. A novel method for measuring antioxidant capacity and ist application to monitoring the antioxidant status in premature neonates. Clin. Sci. 84:1993;407-412.
16. Ghiselli A., Serafini M., Natella F., Scaccini C. Total antioxidant capacity as a tool to assess redox status: critical view and experimental data. Free Radic. Biol. Med. 29:2000;1106-1114.
17. Nguyen-Khoa T., Massy Z.A., Witko-Sarsat V., Thévenin M., Touam M., Lambrey G., Lacour B., Drüeke T.B., Descamps-Latscha B. Critical evaluation of plasma and LDL oxidant-trapping potential in hemodialysis patients. Kidney Int. 56:1999;747-753.
18. Bergesio F., Monzani G., Ciuti R., Pinzani P., Priami F., Cirami C., Ciccarelle C., Salvadori M. Total antioxidant capacity (TAC): is it an effective method to evaluate oxidative stress in uremia? J. Biolumin. Chemilumin. 13:1998;315-319.
19. Clermont G., Lecour S., Lahet J.J., Siohan P., Vergely C., Chevet D., Rifle G., Rochette L. Alterations in plasma antioxidant capacities in chronic renal failure and hemodialysis patients: a possible explanation for the increased cardiovascular risk in these patients. Cardiovasc. Res. 47:2000;618-623.
20. Meucci E., Littarru C., Deli G., Luciani G., Tazza L., Littarru G.P. Antioxidant status and dialysis: plasma and saliva antioxidant acitvity in patients with fluctuating urate levels. Free Radic. Res. 29:1998;367-376.
21. Fiorillo C., Oliviero C., Rizzuti G., Nediani C., Pacini A., Nassi P. Oxidative stress and antioxidant defenses in renal patients receiving regular hemodialysis. Clin. Chem. Lab. Med. 36:1998;149-153.
22. Himmelfarb J., McMenamin E., Monagle E. Plamsa aminothiol oxidation in chronic hemodialysis patients. Kidney Int. 61:2002;705-716.
23. Hofer G., Lichtenberg D., Hermetter A. A new fluorescence method for the continuous determination of surface lipid oxidation in lipoproteins and plasma. Free Radic. Res. 23:1995;317-327.
24. Mayer B., Schumacher M., Brandstätter H., Wagner F.S., Hermetter A. High-throughput fluorescence screening of antioxidative capacity in human serum. Anal. Biochem. 297:2001;144-153.
25. Strube M., Haenen G.R., Van den Berg H., Bast A. Pitfalls in a method for assessment of total antioxidant capacity. Free Radic. Res. 26:1997;515-521.
26. Buss H., Chen T.P., Sluis K.B., Domigan N.M., Winterbourn C.C. Protein carbonyl measurement by a sensitive ELISA method. Free Radic. Biol. Med. 23:1997;361-366.
27. Eiselt J., Racek J., Trefil L., Opatrný K. Effects of vitamin E-modified dialysis membrane and vitamin C infusion on oxidative stress in hemodialysis patients. Artif. Organs. 25:2001;430-436.
28. Srinivasa Rao P.V.L.N., Dakshinamurty K.V., Saibaba K.S.S., Rhagavan M.S.S., Vijayabhaskar M., Sreekrishna V., Ambekar J.G., Jayaseelan L. Oxidative stress in hemodialysis-intradialytic changes. Redox Rep. 6:2001;303-309.
29. Lippa S., Colacicco L., Bondanini F., Callà C., Gozzo M.L., Ciccariello M., Angelitti A.G. Plasmalevels of Coenzyme Q10, vitamin E and lipids in uremic patients on conservative therapy and hemodialysis treatment: some possible biochemical and clinical implications. Clin. Chim. Acta. 292:2000;81-91.
30. Roob J.M., Khoschsorur G., Tiran A., Horina J.H., Holzer H., Winklhofer-Roob B.M. Vitamin E attenuates oxidative stress induced by intravenous iron in patients on hemodialysis. J. Am. Soc. Nephrol. 11:2000;539-549.
31. Zima T., Janebova M., Nemecek K., Bartova V. Retinol and alpha-tocopherol in hemodialysis patients. Ren. Fail. 20:1998;505-512.
32. Hultqvist M., Hegbrant J., Nilsson-Thorell C., Lindholm T., Nilsson P., Linden T., Hultqvist-Bengtsson U. Plasma concentrations of vitamin C, vitamin E and/or malondialdehyde as markers of oxygen free radical production during hemodialysis. Clin. Nephrol. 47:1997;37-46.
33. Galli F., Varga Z., Balla J., Ferraro B., Canestrari F., Floridi A., Kakuk G., Buoncristiani U. Vitamin E, lipid profile, and peroxidation in hemodialysis patients. Kidney Int. 59(Suppl. 78):2001;S148-S154.
34. Nourooz-Zadeh J. Effect of dialysis on oxidative stress in uremia. Redox Rep. 4:1999;17-22.
35. Peuchant E., Delmas-Beauvieux M.C., Dubourg L., Thomas M.J., Perromat A., Aparicio M., Clerc M., Combe C. Antioxidant effects of a supplemented very low protein diet in chronic renal failure. Free Radic. Biol. Med. 22:1997;313-320.
36. Srinavasa-Rao P.V., Dakshinamurty K.V., Saibaba K.S., Sheela R.B., Venkataramana G., Sreekrishna V., Ambekar J.G., Jayaseelan L. Oxidative stress in hemodialysis: immediate changes caused by passage of blood through the dialyser. Ann. Clin. Biochem. 38:2001;401-405.
37. Galli F., Canestrari F., Bellomo G. Pathophysiology of the oxidative stress and its implication in uremia and dialysis. Contrib. Nephrol. 127:1999;1-31.
38. Morena M., Cristol J.-P., Senécal L., Leray Moragues H., Krieter D., Canaud B. Oxidative stress in hemodialysis patients: is NADPH oxidase complex the culprit? Kidney Int. 61:2002;S109-S114.
39. Sirolli V., Ballone E., Di Stante S., Amoroso L., Bonomini M. Cell activation and cellular-cellular interactions during hemodialysis: effect of dialyzer membrane. Int. J. Artif. Organs. 25:2002;529-537.
40. Becker B.F. Towards the physiological function of uric acid. Free Radic. Biol. Med. 14:1993;615-631.
41. Islam K.N., O'Byrne D., Devaraj S., Palmer B., Grundy S.M., Jialal I. Alpha-tocopherol supplementation decreases the oxidative susceptibility of LDL in renal failure patients on dialysis therapy. Atherosclerosis. 150:2000;217-224.
42. Descombes E., Boulat O., Perriard F., Fellay G. Water-soluble vitamin levels in patients undergoing high-flux hemodialysis and receiving long-term oral postdialysis vitamin supplementation. Artif. Organs. 24:2000;773-778.
43. Sezer S., Ozdemir F.N., Yakupoglu U., Arat Z., Turan M., Haberal M. Intravenous ascorbic acid administration for erythropoietin-hyporesponsive anemia in iron loaded hemodialysis patients. Artif. Organs. 26:2002;366-370.
44. Giancaspro V., Nuzziello M., Pallotta G., Sacchetti A., Petrarulo F. Intravenous ascorbic acid in hemodialysis patients with functional iron deficiency: a clinical trial. J. Nephrol. 13:2000;444-449.
45. Tarng D.C., Wei Y.H., Huang T.P., Kuo B.I., Yang W.C. Intravenous ascorbic acid as an adjuvant therapy for recombinant erythropoietin in hemodialysis patients with hyperferritinemia. Kidney Int. 55:1999;2477-2486.
46. Ono K. The effect of vitamin C supplementation and withdrawal on the mortality and morbidity of regular hemodialysis patients. Clin. Nephrol. 31:1989;31-34.
47. Ziouzenkova O., Asatryan L., Tetta C., Wratten M.L., Hwang J., Sevanian A. Oxidative stress during ex vivo hemodialysis of blood is decreased by a novel hemolipodialysis procedure utilizing antioxidants. Free Radic. Biol. Med. 33:2002;248-258.
48. Eiselt J., Racek J., Trefil L., Opatrný K. Effect of a vitamin E-modified dialysis membrane and vitamin C infusion on oxidative stress in hemodialysis patients. Artif. Organs. 25:2001;430-436.
49. Sanaka T., Omata M., Nishimura H., Shinobe M., Higuchi C. Suppressive effects of vitamin E-coated dialysis membrane on hemodialysis-induced neutrophil activation. Contrib. Nephrol. 127:1999;261-268.